{"id":20491,"date":"2025-06-14T13:41:32","date_gmt":"2025-06-14T13:41:32","guid":{"rendered":"https:\/\/gaviki.com\/blog\/?p=20491"},"modified":"2025-06-14T13:41:33","modified_gmt":"2025-06-14T13:41:33","slug":"based-on-the-learning-materials-over-the-course-of-this-term","status":"publish","type":"post","link":"https:\/\/gaviki.com\/blog\/based-on-the-learning-materials-over-the-course-of-this-term\/","title":{"rendered":"Based on the learning materials over the course of this term"},"content":{"rendered":"\n<p>Based on the learning materials over the course of this term, Schedule 1 compounds listed as examples in Appendix 1 may need to be revised based on continued research into recognized medical uses of drugs like MDMA. True False<\/p>\n\n\n\n<p><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><strong>The correct answer and explanation is:<\/strong><\/mark><\/p>\n\n\n\n<p><strong>Correct Answer: True<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Explanation (300 words):<\/h3>\n\n\n\n<p>Schedule 1 compounds, according to many national drug classification systems (such as the United States Controlled Substances Act or similar frameworks in other countries), are substances that are considered to have <em>no currently accepted medical use<\/em>, a <em>high potential for abuse<\/em>, and a <em>lack of accepted safety for use under medical supervision<\/em>. Examples include LSD, heroin, and <strong>MDMA (commonly known as ecstasy)<\/strong>.<\/p>\n\n\n\n<p>However, <strong>this classification is being increasingly challenged by ongoing scientific research<\/strong>, especially regarding MDMA. In recent years, a growing body of peer-reviewed studies has demonstrated that <strong>MDMA may have valid and effective medical applications<\/strong>, particularly in the treatment of <strong>Post-Traumatic Stress Disorder (PTSD)<\/strong>. Clinical trials, including those sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS), have shown that <strong>MDMA-assisted therapy can be significantly more effective than placebo or standard therapies<\/strong> for some patients suffering from severe, treatment-resistant PTSD.<\/p>\n\n\n\n<p>Due to such findings, in 2023, the U.S. Food and Drug Administration (FDA) designated <strong>MDMA-assisted therapy for PTSD as a \u201cBreakthrough Therapy\u201d<\/strong>, which is a step toward potential medical approval. This recognition strongly contradicts the original criteria for a Schedule 1 classification. It implies that the <strong>drug does, in fact, have accepted medical uses<\/strong> under controlled and supervised settings.<\/p>\n\n\n\n<p>Because of this emerging evidence, experts and policymakers have begun calling for a <strong>re-evaluation of the Schedule 1 status of MDMA and similar substances<\/strong>. This aligns with the broader trend of revisiting outdated drug laws that were based more on stigma and moral panic than modern scientific understanding.<\/p>\n\n\n\n<p>Therefore, it is <strong>true<\/strong> that <strong>Schedule 1 compounds listed in Appendix 1 may need to be revised<\/strong> based on ongoing and credible research showing recognized medical uses of drugs like MDMA. This is an important step toward evidence-based drug policy and improved access to innovative treatments.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Based on the learning materials over the course of this term, Schedule 1 compounds listed as examples in Appendix 1 may need to be revised based on continued research into recognized medical uses of drugs like MDMA. True False The correct answer and explanation is: Correct Answer: True Explanation (300 words): Schedule 1 compounds, according [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-20491","post","type-post","status-publish","format-standard","hentry","category-quiz-questions"],"_links":{"self":[{"href":"https:\/\/gaviki.com\/blog\/wp-json\/wp\/v2\/posts\/20491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gaviki.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gaviki.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gaviki.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gaviki.com\/blog\/wp-json\/wp\/v2\/comments?post=20491"}],"version-history":[{"count":1,"href":"https:\/\/gaviki.com\/blog\/wp-json\/wp\/v2\/posts\/20491\/revisions"}],"predecessor-version":[{"id":20492,"href":"https:\/\/gaviki.com\/blog\/wp-json\/wp\/v2\/posts\/20491\/revisions\/20492"}],"wp:attachment":[{"href":"https:\/\/gaviki.com\/blog\/wp-json\/wp\/v2\/media?parent=20491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gaviki.com\/blog\/wp-json\/wp\/v2\/categories?post=20491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gaviki.com\/blog\/wp-json\/wp\/v2\/tags?post=20491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}